Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 2 1Phase 1/2 1

Status

Active not recruiting 2Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 1316Neoplasms 1104Carcinoma, Non-Small-Cell Lung 916Prostatic Neoplasms 747Colorectal Neoplasms 645Lung Neoplasms 621Neoplasm Metastasis 470Multiple Myeloma 444Leukemia, Myeloid, Acute 440Pancreatic Neoplasms 392Ovarian Neoplasms 388Melanoma 346Carcinoma, Hepatocellular 308Brain Neoplasms 290Squamous Cell Carcinoma of Head and Neck 285Recurrence 285Glioblastoma 260Stomach Neoplasms 252Head and Neck Neoplasms 250Precursor Cell Lymphoblastic Leukemia-Lymphoma 238Carcinoma, Renal Cell 237Lymphoma 235Triple Negative Breast Neoplasms 233Endometrial Neoplasms 221Uterine Cervical Neoplasms 217Hematologic Neoplasms 216Urinary Bladder Neoplasms 212Lymphoma, Non-Hodgkin 203Glioma 202Sarcoma 200

Interventions

talimogene laherparepvec 1exemestane 1Tamoxifen 1Surgical Procedures, Operative 1Specimen Handling 1Paclitaxel 1Mastectomy, Segmental 1Letrozole 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Carcinoma, Ductal × 90 days × Clear all
NCT05183828 2026-06-04

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

University of Washington

Phase 4 Terminated
62 enrolled

Carcinoma, Ductal

NCT02926911 2026-05-12

COMET

Alliance Foundation Trials, LLC.

Phase NA Active not recruiting
997 enrolled 16 charts
Breast

Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal

NCT07499999 2026-03-30

BabyTEARS

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting
140 enrolled
Breast

Breast Neoplasms, Carcinoma, Ductal

NCT00185744 2026-03-20

Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

Stanford University

Phase NA Active not recruiting
121 enrolled
Breast

Breast Neoplasms, Carcinoma, Ductal

NCT02779855 2026-03-10

Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 1/2 Completed
50 enrolled 12 charts
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Ductal, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡